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Precursor B-cell lymphoblastic lymphoma (PBLL) is an infrequent subtype of lymphoblastic lymphoma (LBL) that
commonly affected site for the diagnosis is the skin, followed by the head and neck. In this report, we presented a
special case of PBLL located at the left arm and detected with magnetic resonance imaging (MRI) and
ultrasonography (US). This kind of PBLL is similar to a peripheral nerve tumor in clinical and radiographic
manifestation.
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It is already documented that lymphoblastic lymphoma
(LBL) is an uncommon entity of non-Hodgkin’s lymph-
oma (NHL) with an incidence of less than 1% for B-cell
LBL among all NHLs [1,2]. B-cell LBL is composed of
immature lymphocytes that express precursor and B-cell
markers. Although 80% of precursor B-cell neoplasms
present as acute leukemia, a small proportion could
manifest as a mass lesion [3]. We report here a 22-year-
old man with an unusual precursor B-cell lymphoblastic
lymphoma (PBLL) presenting as a mass in the left arm
and extending along the neurovascular bundle, similar
to a neurogenic tumor.
Case presentation
A 22-year-old man was referred to a physician complain-
ing of severe pain for 6 months from a progressively
growing mass in the left arm. Medical history was unre-
markable and the patient was not receiving any medica-
tion. He denied weight loss, night sweats and other
unusual symptoms. Physical examination identified a fu-
siform palpable mass extending from the middle of the
left arm to the elbow, combined with muscle weakness
and numbness on forced flexion and supination. The la-
boratory results of kidney and liver functional tests, as
well as the white blood cell counts and serum lactate* Correspondence: suixf306@163.com
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reproduction in any medium, provided the ordehydrogenase (LDH) levels, were within the normal
range. The cerebrospinal fluid immunocytochemical
analysis, bone marrow aspiration and biopsy showed
negative for any malignancy. In addition, no positive
symptoms were found on chest radiography or abdom-
inal ultrasound (US).
Magnetic resonance imaging (MRI) revealed a well-
defined mass located in the medial compartment of the
left arm, with homogeneous and intermediate signal in-
tensity on the axial T2-weighted image (Figure 1A) and
isointense to skeletal muscle on the axial T1-weighted
image (Figure 1B). The unusual thickened median nerve
was completely encased by the lesion. The axial enhanced
T1-weighted image (Figure 1C) and axial fat-saturated
enhanced T1-weighted image (Figure 1D) mainly showed
mainly uniform enhancement in accordance with the
median nerve. The coronal fat-suppression proton-density
fast spin echo image showed the mass longitudinally
extended along the neurovascular bundle in extension
to the median nerve with measures of 10 × 2 × 2 cm
(Figure 1E). Well-defined margins were noticed on the
coronal blade fat-suppression proton-density image
(Figure 1F).
High-resolution US established a marked hypoechoic
lesion on the left distal arm. The hypoechoic lesion
showed a clear round halo which was completely and
concentrically encased in the median nerve in transverse
sonograms. The median nerve was much larger than
normal and was characterized by swollen fascicles
(Figure 2A). Longitudinal sonograms revealed the well-. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 The axial T2-weighted image revealed a homogeneously intermediate signal lesion located within the medial compartments
in the left arm. The hypo-intense median nerve is completely encased by the round-shaped mass (A). On the axial T1-weighted image (B) the
lesion is isointense to skeletal muscle. The axial enhanced T1-weighted image (C) and axial fat-saturated enhanced T1-weighted image (D) show
mildly uniform enhancement and a small area of necrosis. The coronal fat-suppression proton-density fast spin echo image. (E) demonstrates the
mass in direct continuity with the median nerve with a fusiform shape. A well-defined lesion is noted on the coronal blade fat-suppression
proton-density image (F).
Sui et al. World Journal of Surgical Oncology 2012, 10:140 Page 2 of 6
http://www.wjso.com/content/10/1/140defined lesion extending along the median nerve
(Figure 2B). Color Doppler sonography demonstrated
avascular flow signals in the lesion (Figure 2C). The
margin of the biceps brachii muscle slightly abutting the
mass showed some hyervascularization on the color
Doppler image (Figure 2D), while the basilic vein and
ulnar nerve were normal.Through surgery, a well-defined and fusiform mass
was found on the left arm. The tumor extending along
the neurovascular bundle and in continuity with the me-
dian nerve seemed to originate from the median nerve.
After resection of the fragile fleshy mass, the marked
swollen median nerve was also noticed (Figure 3). The
median nerve was completely encased by the mass.
Figure 2 Sonography images demonstrated a lesion encased the swollen median nerve. (A) The transverse sonogram shows a round
hypoechoic halo with well-defined margins and posterior acoustic enhancement completely surrounded the swollen median nerve. The brachial
artery was partially encased, while the basilic vein and ulnar nerve were unaffected. (B) The longitudinal sonogram shows the mass extended
along the median nerve. The swollen nerve shows hypoechoic echotexture lesion with discernible fascicles. The adjacent biceps brachii muscle
with inhomogeneous-reduced echogenity is noted. (C) Avascularity could be visualized on the color Doppler image inside the mass. (D) Slightly
increased vascularity is observed on color doppler sonography in biceps brachii muscle adjacent to the lesion.
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Figure 4 Histologic analysis revealed monomorphic infiltration
from lymphoblasts, showing scant cytoplasm and irregular
nuclei. (A) Diffuse, uniform, small-to-intermediated sized cells
(H & E, ×200). (B) Scant cytoplasm, condensed chromatin and
inconspicuous nucleoli; mitotically active lymphoma cells
(H & E, ×400). (C) Infiltration of the fibro-fatty tissue (H & E, ×200).
Figure 3 The intraoperative photograph shows the swollen and
enlarged median nerve after resection of the lesion.
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morphic infiltration from small to intermediate-sized
lymphoblasts (Figure 4A) showing scant cytoplasm and
irregular nuclei with a high mitotic rate (Figure 4B), in-
filtrating among the fibro-fatty tissue (Figure 4C). Based
on the immunohistochemical analysis, most of the lym-
phocytes stained positively for CD20, TDT, CD45, CD99,
CD34, CD43, and negatively for CD3. Immunostaining
for Ki-67 showed positive immunostaining of more than
90% of the lymphocytes. A diagnosis of precursor B-cell
lymphoblastic lymphoma (PBLL) was rendered.
Clinical symptoms including severe pain and numb-
ness were relieved soon after the surgical procedure of
decompression. Local radiotherapy was applied to his
left arm. PET and Gallium scintigraphy were not per-
formed at diagnosis under cost constraints. He received
two cycles of cyclophosphamide, doxorubicin, vincris-
tine, and prednisone (CHOP) chemotherapy in the fol-
lowing 2 months. The patient was readmitted to our
hospital due to persistent headache for a week before
initiation of further chemotherapy. Cerebrospinal fluid
(CSF) examination showed glucose 2.90 mmol/L, in-
creased protein at 0.60 g/L, 90% mononuclear cells, 10%
polykaryocytes, karyocyte count 90 × 106/L, and no red
blood cells (RBCs). The diagnosis of central nervous sys-
tem (CNS) involvement was established. MRI of the
brain was unremarkable. Neck, chest, and abdomino-
pelvic sonography revealed no other involvement site ex-
cept for a few axillary lymph nodes less than 10 mm in
size. The patient died of multiple organ failure early in
the course of high-dose methylprednisolone treatment
shortly after being readmitted. Request for autopsy was
denied.
Discussion
LBL is a rare disease that shares the same biologic fea-
tures as the acute lymphoblastic leukemia (ALL). Indeed,LBL and ALL are considered to be a single entity
(lymphoblastic leukemia/lymphoma T and B types) in
the World Health Organization (WHO) classification of
precursor lymphoid neoplasms [4]. LBL is committed to
the T-cell lineage (T-LBL), B-(B-LBL), or NK-cell lineage
(NK-LBL) with an incidence of less than 2% within all
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lymphoma respectively, even fewer for NK-lymphoblastic
lymphoma [2]. T-cell type usually presents with a medi-
astinal mass and cervical lymphadenopathy. However,
B-LBL often occurs within skin and bone involvement,
except for a small proportion involving soft tissue and
presenting with a mass lesion [5,6]. Localized invasion of
peripheral nerves of extra-nodal LBL, a unique uncommon
subtype, was termed as neurolymphomatosis [7].
The presenting signs and symptoms with LBL are
shown in the primary sites where the disease is involved
[8]. However, the clinical signs and symptoms are usu-
ally unspecific, which may pose a diagnostic problem. A
technologically less complex needle biopsy may yield a
diagnosis. However, our case was not possible to safely
perform this procedure, as the biopsy may place the pa-
tient at very high risk of nerve and vessel injury. There-
fore, a more invasive procedure should be performed for
more reliable diagnosis. Imaging studies play a very im-
portant role to illustrate the relationship between the le-
sion and the adjacent tissue before the operation.
The MRI findings in our patient are similar to those
of musculoskeletal lymphoma in the previous studies
[9,10], such as predominantly homogeneous, intermedi-
ate signal intensity between those of fat and muscle on
the T2-weighted image, and equal signal intensity com-
pared with normal muscle on the T1-weighted image.
The uncommon growth pattern of extension along the
neurovascular bundle may represent infiltration along
the lymphatic system.
The advantage of sonography in comparison with MRI
is its ability to trace the imaged nerve segments in a
single study and with superior resolution [11]. The en-
casement of the median nerve with loss of fascicular
discrimination resembled the sonography of peripheral
nerve compression, which seemed to occur secondary
to schwannoma deriving from the nerve sheath [12]. How-
ever, three differences from nerve compression were still
considered in this case. First, the sonographic appear-
ance of the transverse median nerve was round-shaped
in our patient, which was different from the somewhat
flattened appearance in the entrapment neuropathies.
Second, the nerve commonly showed a focal thinning in
diameter at the site of direct compression, while our pa-
tient demonstrated marked swelling of the median nerve
without reduction in nerve diameter. Third, color Dop-
pler sonography in our patient revealed scarce intra- and
perineural Doppler signals in the median nerve, whereas
an increase in intraneural and perineural flow signals in
color Doppler or power Doppler images was commonly
seen in nerve compression [11].
PBLL is a highly aggressive subtype of lymphoma,
with frequent bone marrow involvement, and a 5% to
10% incidence of CNS involvement [1]. Positive CNSinvolvement is defined as the presence of 5 × 106/L or
more white blood cells (WBCs) on CSF cytospin. The
presence of CNS leukemia is an adverse prognostic fac-
tor and a potentially fatal complication of lymphoma
[13]. The main cause of death in neurolymphomatosis is
disseminated disease with associated multi-organ failure
[14], as was seen in our patient. Peripheral neuropathy
as a complication of lymphoma is not common, affecting
only 0.1% to 2.0% of patients. The tumor may arise
within aberrant lymph nodes, behaving as an infiltrative
lesion instead of a compartmental condition [4,5]. The
variable cells might possess stronger affinity to endothe-
lial cells at the blood-nerve barrier, which would allow
easier passage of the lymphoma cells into the peripheral
nervous system. Sonographic and MRI assessment of the
extent of the damaged median nerve in our patient was
very beneficial. Explorative surgical treatment was very
challenging in this case. Nonetheless the reasons for the
procedure may be discerned in general: Firstly, proven
median nerve compression inside the lesion surgical de-
compression was advocated; Secondly, an exact diagnos-
tic work-up was mandatory to achieve an establishment
of reliably histopathologic diagnosis.
Conclusions
We experienced a PBLL presenting as a mass, and pos-
ing diagnostic difficulties for the referring clinician and
radiologist. This could be mistaken for an enlarged neu-
rogenic tumor.
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